U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

See more countries

Results: 1 to 20 of 34

Tests names and labsConditionsGenes, analytes, and microbesMethods

TGM5 Gene Peeling skin syndrome type 2 NGS Genetic DNA Test

DNA Labs India
India
11
  • S Mutation scanning of the entire coding region

ENAM Gene Amelogenesis imperfecta type 1B NGS Genetic DNA Test

DNA Labs India
India
11
  • S Mutation scanning of the entire coding region

ENAM Gene Amelogenesis imperfecta type 1C NGS Genetic DNA Test

DNA Labs India
India
11
  • S Mutation scanning of the entire coding region

ENAM - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Amelogenesis imperfecta and related disorders Comprehensive panel

HNL Genomics Connective Tissue Gene Tests
United States
116
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Amelogenesis imperfecta and related disorders NGS panel

HNL Genomics Connective Tissue Gene Tests
United States
116
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Amelogenesis imperfecta and related disorders Deletion/ Duplication panel

HNL Genomics Connective Tissue Gene Tests
United States
116
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Amelogenesis imperfecta, type IC, 204650, Autosomal recessive; AI1C (Amelogenesis imperfecta) (ENAM gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Amelogenesis imperfecta, type IB, 104500, Autosomal dominant; AI1B (Amelogenesis imperfecta) (ENAM gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Amelogenesis imperfecta and related disorders NGS panel

HNL Genomics Connective Tissue Gene Tests
United States
116
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Amelogenesis imperfecta and related disorders Comprehensive panel

HNL Genomics Connective Tissue Gene Tests
United States
116
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Amelogenesis imperfecta and related disorders Deletion/ Duplication panel

HNL Genomics Connective Tissue Gene Tests
United States
116
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Amelogenesis and Dentinogenesis Imperfecta Panel

PreventionGenetics, part of Exact Sciences
United States
2834
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Amelogenesis Imperfecta via the ENAM Gene

PreventionGenetics, part of Exact Sciences
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Amelogénesis imperfecta tipo IB,C (sequence analysis of ENAM gene)

CGC Genetics Unilabs
Portugal
11
  • C Sequence analysis of the entire coding region

SKELETAL DYSPLASIAS PANEL

Laboratorio de Genetica Clinica SL
Spain
1643
  • E Sequence analysis of select exons

Amelogenesis imperfecta and dentinogenesis imperfecta panel. NGS panel of 15 genes.

Genologica Medica
Spain
2214
  • C Sequence analysis of the entire coding region

Amelogenesis imperfecta

Bioarray
Spain
121
  • C Sequence analysis of the entire coding region

Amelogenesis

Bioarray
Spain
1172
  • C Sequence analysis of the entire coding region

Genomic Unity® Custom Analysis

Variantyx, Inc.
United States
14054
  • D Deletion/duplication analysis
  • X Mutation scanning of select exons
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 34

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.